What is VivoSim Labs, Inc. Common Stock's Market Cap?

VivoSim Labs, Inc. Common Stock's Market Cap is $4.2M, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's Enterprise Value?

VivoSim Labs, Inc. Common Stock's Enterprise Value is $2.5M, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's Price / Sales?

VivoSim Labs, Inc. Common Stock's Price / Sales is 37.4×, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's EV / Revenue?

VivoSim Labs, Inc. Common Stock's EV / Revenue is 22.4×, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's EV / EBITDA?

VivoSim Labs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's Revenue (TTM)?

VivoSim Labs, Inc. Common Stock's Revenue (TTM) is $112.0K, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's Net Income (TTM)?

VivoSim Labs, Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's EBITDA?

VivoSim Labs, Inc. Common Stock's EBITDA is -$11.1M, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's Diluted EPS (TTM)?

VivoSim Labs, Inc. Common Stock's Diluted EPS (TTM) is -0.83, based on as-reported figures from SEC (XBRL) filings.

What is VivoSim Labs, Inc. Common Stock's EBITDA Margin?

VivoSim Labs, Inc. Common Stock's EBITDA Margin is -9943.8%, based on as-reported figures from SEC (XBRL) filings.

VivoSim Labs, Inc. Common Stock (VIVS) Financial Statements

VivoSim Labs, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001V10TP9

XNAS · usd

0.28▲ 0.00 (1.26%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.28

Day's Range0.27 – 0.29

52-Week Range0.26 – 5.30

Volume691.2K

Avg Volume4.6M

Share Statistics

Shares Outstanding

Employees9

ExchangeXNAS

Listed2011-08-16

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about VivoSim Labs, Inc. Common Stock (VIVS)

What is VivoSim Labs, Inc. Common Stock's Market Cap?: VivoSim Labs, Inc. Common Stock's Market Cap is $4.2M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Enterprise Value?: VivoSim Labs, Inc. Common Stock's Enterprise Value is $2.5M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Price / Sales?: VivoSim Labs, Inc. Common Stock's Price / Sales is 37.4×, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EV / Revenue?: VivoSim Labs, Inc. Common Stock's EV / Revenue is 22.4×, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EV / EBITDA?: VivoSim Labs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Revenue (TTM)?: VivoSim Labs, Inc. Common Stock's Revenue (TTM) is $112.0K, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Net Income (TTM)?: VivoSim Labs, Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EBITDA?: VivoSim Labs, Inc. Common Stock's EBITDA is -$11.1M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Diluted EPS (TTM)?: VivoSim Labs, Inc. Common Stock's Diluted EPS (TTM) is -0.83, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EBITDA Margin?: VivoSim Labs, Inc. Common Stock's EBITDA Margin is -9943.8%, based on as-reported figures from SEC (XBRL) filings.